These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 1613791)

  • 1. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
    Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
    J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
    Zagorski MG; Barrow CJ
    Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.
    Barrow CJ; Zagorski MG
    Science; 1991 Jul; 253(5016):179-82. PubMed ID: 1853202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
    Otvos L; Szendrei GI; Lee VM; Mantsch HH
    Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions.
    Orlando R; Kenny PT; Zagorski MG
    Biochem Biophys Res Commun; 1992 Apr; 184(2):686-91. PubMed ID: 1575742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells.
    Buchet R; Tavitian E; Ristig D; Swoboda R; Stauss U; Gremlich HU; de La Fournière L; Staufenbiel M; Frey P; Lowe DA
    Biochim Biophys Acta; 1996 Jan; 1315(1):40-6. PubMed ID: 8611645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and secondary structural studies of penta(acetyl-Hmb)A beta(1-40).
    Clippingdale AB; Macris M; Wade JD; Barrow CJ
    J Pept Res; 1999 Jun; 53(6):665-72. PubMed ID: 10408341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free Energy Landscape for Alpha-Helix to Beta-Sheet Interconversion in Small Amyloid Forming Peptide under Nanoconfinement.
    Mudedla SK; Murugan NA; Agren H
    J Phys Chem B; 2018 Oct; 122(42):9654-9664. PubMed ID: 30253649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils.
    El-Agnaf OM; Bodles AM; Guthrie DJ; Harriott P; Irvine GB
    Eur J Biochem; 1998 Nov; 258(1):157-63. PubMed ID: 9851705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
    Shao H; Jao S; Ma K; Zagorski MG
    J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation.
    Sonar K; Mancera RL
    J Phys Chem B; 2022 Oct; 126(40):7916-7933. PubMed ID: 36179370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
    Mandal PK; Pettegrew JW
    Neurochem Res; 2004 Dec; 29(12):2267-72. PubMed ID: 15672549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature-dependent beta-sheet formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-structure folding from aggregation.
    Gursky O; Aleshkov S
    Biochim Biophys Acta; 2000 Jan; 1476(1):93-102. PubMed ID: 10606771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
    Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
    Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-dependent conformations of the amyloid beta(1-28) peptide fragment explored using molecular dynamics.
    Kirshenbaum K; Daggett V
    Biochemistry; 1995 Jun; 34(23):7629-39. PubMed ID: 7779809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.
    Crescenzi O; Tomaselli S; Guerrini R; Salvadori S; D'Ursi AM; Temussi PA; Picone D
    Eur J Biochem; 2002 Nov; 269(22):5642-8. PubMed ID: 12423364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.